These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of pH, temperature, and salt on the stability of Escherichia coli- and Chinese hamster ovary cell-derived IgG1 Fc. Li CH; Narhi LO; Wen J; Dimitrova M; Wen ZQ; Li J; Pollastrini J; Nguyen X; Tsuruda T; Jiang Y Biochemistry; 2012 Dec; 51(50):10056-65. PubMed ID: 23078371 [TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of IgG1 with asymmetrical Fc glycosylation. Ha S; Ou Y; Vlasak J; Li Y; Wang S; Vo K; Du Y; Mach A; Fang Y; Zhang N Glycobiology; 2011 Aug; 21(8):1087-96. PubMed ID: 21470983 [TBL] [Abstract][Full Text] [Related]
5. The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragments. Leung SO; Qu Z; Hansen HJ; Shih LB; Wang J; Losman MJ; Goldenberg DM; Sharkey RM Clin Cancer Res; 1999 Oct; 5(10 Suppl):3106s-3117s. PubMed ID: 10541351 [TBL] [Abstract][Full Text] [Related]
6. [Therapeutic antibodies and related products: choosing the right structure for success]. Beck A; Wagner-Rousset E; Wurch T; Corvaia N Med Sci (Paris); 2009 Dec; 25(12):1024-32. PubMed ID: 20035674 [TBL] [Abstract][Full Text] [Related]
7. Control of IgG LC:HC ratio in stably transfected CHO cells and study of the impact on expression, aggregation, glycosylation and conformational stability. Ho SC; Koh EY; van Beers M; Mueller M; Wan C; Teo G; Song Z; Tong YW; Bardor M; Yang Y J Biotechnol; 2013 Jun; 165(3-4):157-66. PubMed ID: 23583871 [TBL] [Abstract][Full Text] [Related]
8. Acid-induced aggregation of human monoclonal IgG1 and IgG2: molecular mechanism and the effect of solution composition. Hari SB; Lau H; Razinkov VI; Chen S; Latypov RF Biochemistry; 2010 Nov; 49(43):9328-38. PubMed ID: 20843079 [TBL] [Abstract][Full Text] [Related]
9. Generation and comparative characterization of glycosylated and aglycosylated human IgG1 antibodies. Hristodorov D; Fischer R; Joerissen H; Müller-Tiemann B; Apeler H; Linden L Mol Biotechnol; 2013 Mar; 53(3):326-35. PubMed ID: 22427250 [TBL] [Abstract][Full Text] [Related]
10. Optimization of humanized IgGs in glycoengineered Pichia pastoris. Li H; Sethuraman N; Stadheim TA; Zha D; Prinz B; Ballew N; Bobrowicz P; Choi BK; Cook WJ; Cukan M; Houston-Cummings NR; Davidson R; Gong B; Hamilton SR; Hoopes JP; Jiang Y; Kim N; Mansfield R; Nett JH; Rios S; Strawbridge R; Wildt S; Gerngross TU Nat Biotechnol; 2006 Feb; 24(2):210-5. PubMed ID: 16429149 [TBL] [Abstract][Full Text] [Related]
11. Aglycosylated antibodies and the methods of making and using them: WO2008030564. Jefferis R Expert Opin Ther Pat; 2009 Jan; 19(1):101-5. PubMed ID: 19441902 [TBL] [Abstract][Full Text] [Related]
12. A thermal-cycling method for disaggregating monoclonal antibody oligomers. Sadavarte RH; Ghosh R J Pharm Sci; 2014 Mar; 103(3):870-8. PubMed ID: 24549731 [TBL] [Abstract][Full Text] [Related]
13. Impact of deglycosylation and thermal stress on conformational stability of a full length murine IgG2a monoclonal antibody: observations from molecular dynamics simulations. Wang X; Kumar S; Buck PM; Singh SK Proteins; 2013 Mar; 81(3):443-60. PubMed ID: 23065923 [TBL] [Abstract][Full Text] [Related]
14. Effect of constant and variable domain glycosylation on pharmacokinetics of therapeutic antibodies in mice. Millward TA; Heitzmann M; Bill K; Längle U; Schumacher P; Forrer K Biologicals; 2008 Jan; 36(1):41-7. PubMed ID: 17890101 [TBL] [Abstract][Full Text] [Related]